Agnirva Space Premier League - Expedition #31996: Developing Space-Based Vaccines: The Recombinant Attenuated Salmonella Vaccine Experiment

The Recombinant Attenuated Salmonella Vaccine experiment is an innovative study that explores the development of vaccines for space travelers. Led by Principal Investigator Cheryl Nickerson, Ph.D., from Arizona State University, Tempe, this experiment focuses on developing a recombinant attenuated Salmonella vaccine, which could be vital for preventing infections during long-duration space missions.

Space missions, particularly those that last for extended periods, present unique health challenges for astronauts. One of the risks is the increased susceptibility to infections due to the altered immune response in microgravity. The recombinant attenuated Salmonella vaccine aims to address this risk by enhancing astronauts' immunity to Salmonella, a pathogen that can cause foodborne illness.

This experiment is an important step toward developing effective vaccines for space travelers, ensuring their health and safety during missions. The vaccine could not only protect astronauts but also benefit people on Earth, particularly in areas with limited access to medical resources.

Learn more about the Recombinant Attenuated Salmonella Vaccine experiment by visiting the official NASA page: [NASA ISS Science](https://www.nasa.gov/iss-science/).

Get certified with over 100 hours of immersive, self-paced learning in astronomy, cosmology, space technology, and climate science through the Agnirva Space Internship Program. Join, complete virtual projects, and earn a digital certificate to showcase your space fluency in interviews, resumes, and beyond.